Article Versions Notes

Gagliardi A, Voci S, Ambrosio N, Fresta M, Duranti A, Cosco D. Characterization and Preliminary In Vitro Antioxidant Activity of a New Multidrug Formulation Based on the Co-Encapsulation of Rutin and the α-Acylamino-β-Lactone NAAA Inhibitor URB894 within PLGA Nanoparticles. Antioxidants. 2023; 12(2):305. https://doi.org/10.3390/antiox12020305

Gagliardi, Agnese, Silvia Voci, Nicola Ambrosio, Massimo Fresta, Andrea Duranti, and Donato Cosco. 2023. "Characterization and Preliminary In Vitro Antioxidant Activity of a New Multidrug Formulation Based on the Co-Encapsulation of Rutin and the α-Acylamino-β-Lactone NAAA Inhibitor URB894 within PLGA Nanoparticles" Antioxidants 12, no. 2: 305. https://doi.org/10.3390/antiox12020305

Gagliardi, A., Voci, S., Ambrosio, N., Fresta, M., Duranti, A., & Cosco, D. (2023). Characterization and Preliminary In Vitro Antioxidant Activity of a New Multidrug Formulation Based on the Co-Encapsulation of Rutin and the α-Acylamino-β-Lactone NAAA Inhibitor URB894 within PLGA Nanoparticles. Antioxidants, 12(2), 305. https://doi.org/10.3390/antiox12020305